161 related articles for article (PubMed ID: 9491201)
21. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
Neidhart M
J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
[TBL] [Abstract][Full Text] [Related]
23. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
[TBL] [Abstract][Full Text] [Related]
24. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
25. Anticardiolipin antibodies and disease activity in systemic lupus erythematosus.
Santiago MB; Viana V; Bueno C; Yoshinari N; de Oliveira RM; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):167-70. PubMed ID: 2135827
[TBL] [Abstract][Full Text] [Related]
26. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus].
Pozsonyi T; Lakos G; Jakab L; Baraczka K; Jánoskuti L; Kleiber M; Sipka S; Pajor A; Szegedi G
Orv Hetil; 1998 Oct; 139(40):2363-8. PubMed ID: 9796352
[TBL] [Abstract][Full Text] [Related]
28. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.
Saxena R; Saraya AK; Dhot PS; Singh Y; Malaviya AN
Natl Med J India; 1994; 7(4):163-5. PubMed ID: 7950946
[TBL] [Abstract][Full Text] [Related]
29. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
30. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
Yoshio T; Masuyama J; Sumiya M; Minota S; Kano S
J Rheumatol; 1994 Nov; 21(11):2058-63. PubMed ID: 7869310
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
[TBL] [Abstract][Full Text] [Related]
32. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus.
Plazak W; Gryga K; Milewski M; Podolec M; Kostkiewicz M; Podolec P; Musial J
Lupus; 2011 Aug; 20(9):936-44. PubMed ID: 21636627
[TBL] [Abstract][Full Text] [Related]
33. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus.
Ernerudh J; Olsson T; Lindström F; Skogh T
J Neurol Neurosurg Psychiatry; 1985 Aug; 48(8):807-13. PubMed ID: 3875690
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction.
Winfield JB; Shaw M; Silverman LM; Eisenberg RA; Wilson HA; Koffler D
Am J Med; 1983 May; 74(5):837-44. PubMed ID: 6837607
[TBL] [Abstract][Full Text] [Related]
36. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
[TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
Ames PR; Pyke S; Iannaccone L; Brancaccio V
Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
[TBL] [Abstract][Full Text] [Related]
38. Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies.
Ferro D; Pignatelli P; Loffredo L; Conti F; Valesini G; D'Angelo A; Violi F
Arthritis Rheum; 2004 May; 50(5):1693-4. PubMed ID: 15146442
[No Abstract] [Full Text] [Related]
39. Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction.
Duarte-García A; Romero-Díaz J; Juárez S; Cicero-Casarrubias A; Fragoso-Loyo H; Núñez-Alvarez C; Llorente L; Sánchez-Guerrero J
PLoS One; 2018; 13(5):e0196487. PubMed ID: 29723220
[TBL] [Abstract][Full Text] [Related]
40. Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.
Fields RA; Sibbitt WL; Toubbeh H; Bankhurst AD
Ann Rheum Dis; 1990 Feb; 49(2):114-7. PubMed ID: 2317112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
